Cleave Therapeutics is a developer of oncology pharmaceuticals designed to target neurodegeneration and pathways used by cancer cells to grow. It is engaged in the discovery of small-molecule drugs that affect protein-degradation pathways, upon which cancer cells depend on survival, enabling patients to get a cure from cancer.